Stevanato Group to Present at Upcoming Investor Conference
November 10 2022 - 4:01PM
Business Wire
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider
of drug containment, drug delivery, and diagnostic solutions to the
pharmaceutical, biotechnology, and life sciences industries,
announced today that management will present at the Jefferies
London Healthcare Conference at 12:55 p.m. (GMT) on November 17,
2022.
A webcast will be available on the “Investors” section of the
Company’s website, www.stevanatogroup.com. To access the link,
click the “Investors” tab at the top of the website and the webcast
will be available under the “IR Calendar” on the “News &
Events” page.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of
drug containment, drug delivery and diagnostic solutions to the
pharmaceutical, biotechnology, and life sciences industries. The
Group delivers an integrated, end-to-end portfolio of products,
processes and services that address customer needs across the
entire drug life cycle at each of the development, clinical and
commercial stages. Stevanato Group’s core capabilities in
scientific research and development, its commitment to technical
innovation and its engineering excellence are central to its
ability to offer value added solutions to clients.
For more information, please visit www.stevanatogroup.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221110005832/en/
Media Stevanato Group media@stevanatogroup.com
Investor Relations Lisa Miles
lisa.miles@stevanatogroup.com
Stevanato (NYSE:STVN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Stevanato (NYSE:STVN)
Historical Stock Chart
From Sep 2023 to Sep 2024